240 results on '"Selaru, Florin M"'
Search Results
2. A combination therapy of bortezomib, CXCR4 inhibitor, and checkpoint inhibitor is effective in cholangiocarcinoma in vivo
3. Adipokine C1q/Tumor Necrosis Factor- Related Protein 3 (CTRP3) Attenuates Intestinal Inflammation Via Sirtuin 1/NF-κB Signaling
4. Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
5. Prognostic Value of Lymph Node Ratio in Patients with Resected Synchronous Colorectal Liver Metastases and Less Than 12 Examined Lymph Nodes
6. A patient-like swine model of gastrointestinal fibrotic strictures for advancing therapeutics
7. Transitional changes in gastrointestinal transit and rectal sensitivity from active to recovery of inflammation in a rodent model of colitis
8. Impedance Planimetry for Crohnʼs Disease Anastomotic Stricture Characterization: A Predictor of Treatment Response?
9. Challenges in IBD Research 2024: Novel Technologies.
10. Successful liver-directed gene delivery by ERCP-guided hydrodynamic injection (with videos)
11. Use of Biologics for the Treatment of Inflammatory Conditions of the Pouch: A Systematic Review.
12. Current and emerging therapeutic strategies for perianal fistula in Crohn’s disease patients
13. PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease.
14. Extracellular Vesicles in Hepatocellular Carcinoma: Progress and Challenges in the Translation from the Laboratory to Clinic.
15. Extracellular vesicles as novel therapeutics in hepatic failure
16. Exosome miR‐335 as a novel therapeutic strategy in hepatocellular carcinoma
17. Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease.
18. Extracellular vesicles carry microRNA‐195 to intrahepatic cholangiocarcinoma and improve survival in a rat model
19. Non-Viral Gene Delivery to Hepatocellular Carcinoma via Intra-Arterial Injection.
20. A Novel Patient-like Swine Model of Perianal Crohn's Disease.
21. MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer
22. Mo1784 HIGH-RESOLUTION IMPEDANCE PLANIMETRY CHARACTERIZES THE MECHANICAL FEATURES OF CROHN'S DISEASE STRICTURES – IMPLICATIONS FOR PATIENT STRATIFICATION
23. 1239 PAIN IN INFLAMMATORY BOWEL DISEASE: A FUNCTION OF DISEASE ACTIVITY OR CENTRAL SENSITIZATION?
24. Su1748 MUCOSAL IMMUNE CHANGES ASSOCIATED WITH USTEKINUMAB THERAPY IN ULCERATIVE COLITIS
25. Sa2029 AN INJECTABLE NANOFIBER-HYDROGEL-EXOSOME GEL IS EFFECTIVE IN A CROHN'S DISEASE PERIANAL FISTULA MODEL
26. Tu1584 INTRATUMORAL IMMUNE MODULATION FOR HEPATOCELLULAR CARCINOMA
27. Initial Clinical Outcomes Using Umbilical Cord–Derived Tissue Grafts to Repair Anovaginal Fistula.
28. Quaternary nanoparticles enable sustained release of bortezomib for hepatocellular carcinoma.
29. Reply
30. MicroRNAs in the Biology and Diagnosis of Cholangiocarcinoma
31. The miR-106b-25 Polycistron, Activated by Genomic Amplification, Functions as an Oncogene by Suppressing p21 and Bim
32. Autonomous Untethered Microinjectors for Gastrointestinal Delivery of Insulin.
33. Biostimulatory Micro‐Fragmented Nanofiber‐Hydrogel Composite Improves Mesenchymal Stem Cell Delivery and Soft Tissue Remodeling.
34. miRNA-Based Therapeutic Strategies
35. Human bile contains MicroRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis
36. Tu1558 A NOVEL COMBINATION TREATMENT INCLUDING BORTEZOMIB, CXCR4 INHIBITION AND CHECK POINT INHIBITION IS EFFECTIVE IN CHOLANGIOCARCINOMA IN VIVO
37. Tu1818 ADIPOKINE C1Q/TUMOR NECROSIS FACTOR-RELATED PROTEIN 3 (CTRP3) ATTENUATES INTESTINAL INFLAMMATION VIA SIRTUIN 1 (SIRT1)/NF-KB SIGNALING
38. Tu1254 A SUSTAINED RELEASE ANTIFIBROTIC IN PRECLINICAL MODELS OF CROHN'S AND OTHER GI TRACT STRICTURES
39. An LOH and mutational investigation of the ST7 gene locus in human esophageal carcinoma
40. Connecting the Dots From Fatty Acids to Nonalcoholic Steatohepatitis: Epigenetics in the Spotlight
41. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon
42. Antibody Response 3 Months After 2-Dose SARS-CoV-2 mRNA Vaccination in Patients With Inflammatory Bowel Disease.
43. A single microRNA species coordinately downregulates multiple targets involved in cell cycle progression in human cholangiocarcinoma: 1269
44. MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint
45. Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer
46. MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint
47. Epigenetic Events in Gastrointestinal Cancer
48. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3#
49. Gastrointestinal Stromal Tumor Causing Obscure-Occult Gastrointestinal Bleeding
50. Prediction of survival in patients with esophageal carcinoma using artificial neural networks
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.